Mesoblast | MSB - EPS Earnings Per Share

Stock Price
2.08
Daily Change
0.06 2.97%
Monthly
-14.05%
Yearly
0.97%
Q1 Forecast
2.07

Mesoblast reported $-0.04 in EPS Earnings Per Share for its fiscal semester ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026H2 Jun/2026 -0.01 -0.04 May/29 2026
FY2026H1 Dec/2025 -0.01 -0.04 Feb/26 2026
FY2025H2 Jun/2025 -0.04 -0.04 -41273000.0000 Aug/28 2025
FY2025H1 Dec/2024 -0.04 -0.02 -0.02 Feb/26 2025
FY2024H2 Jun/2024 -0.03 -0.05 Aug/28 2024




Eps Change Date
Avita Medical AUD -0.38 0 Dec/2025
Clinuvel Pharmaceuticals AUD 0.44 0.16 Jun/2025
Cochlear AUD 3.13 0.25 Dec/2025
CSL USD 5.07 3 Dec/2025
Pacific Edge NZD -0.02 0 Dec/2025
Paradigm Biopharmaceuticals AUD -0.02 0.01 Jun/2025
PYC Therapeutics AUD -0.04 0.01 Dec/2025
Ramsay Health Care AUD 0.66 0.01 Dec/2025
Sonic Healthcare AUD 0.53 0.04 Dec/2025
Starpharma Holdings AUD 0 0.01 Dec/2025
Telix Pharmaceuticals AUD -0.05 0.33 Dec/2025